J.E. Bray

Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes.

J.E. Bray, R. U. Lemieux, T. A. McPherson · The Journal of Immunology · 1981 · 43 citations · Full text

Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden.

J.E. Bray, Grant D. MacLean, Frances Dusel et al. · PubMed · 1982 · 38 citations · Full text

Disease Burden, Immunology, Gastroenterology +19

Lithium and the mitogenic response of human lymphocytes

J.E. Bray, A. Robert Turner, Frances Dusel · Clinical Immunology and Immunopathology · 1981 · 23 citations

Mitogenic Response, Cell Division, Physiology +7

Subpopulations of multiparous rat lymph‐node cells cytotoxic for rat tumour cells and capable of suppressing cytotoxicity <i>in vitro</i>

Robert C. Rees, J.E. Bray, R. A. Robins et al. · International Journal of Cancer · 1975 · 22 citations

Radioiodinated peanut lectin: A potential radiopharmaceutical for immunodetection of carcinoma expressing the T antigen

Pamela Zabel, A.A. Noujaim, A. Shysh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1983 · 15 citations

Cancer Immunosurveillance, Potential Radiopharmaceutical, Immunology +6